Keywords: Merck & Co, Chimerix, CMX157, HIV, CMX001, AIDS, Fiocruz, ARV production, Mozambique, Africa
Merck & Co in-licenses Chimerix antiviral; Fiocruz to make ARVs in Africa
Article | 24 July 2012
USA-based Chimerix, a venture-funded biotech focused on developing novel oral antivirals, has announced a license agreement granting US drugs giant ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
